AGÕæÈ˹ٷ½

STOCK TITAN

[Form 3] NeoGenomics, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

NeoGenomics has filed a Form 3 (Initial Statement of Beneficial Ownership) announcing the appointment of Marjorie C. Green as a Director of the company, effective June 19, 2025. The filing discloses that:

  • Green currently owns no securities or derivative securities of NeoGenomics
  • She serves as a Director but holds no other positions (such as Officer or 10% Owner)
  • The filing was submitted individually, not as part of a group
  • The document was signed by Ali Olivo as Attorney-in-Fact on June 24, 2025

This Form 3 filing is a standard regulatory requirement for new company insiders under Section 16(a) of the Securities Exchange Act of 1934, establishing their initial ownership position upon assuming their role.

NeoGenomics ha presentato un Modulo 3 (Dichiarazione Iniziale di Proprietà Beneficiaria) annunciando la nomina di Marjorie C. Green come Direttrice della società, con effetto dal 19 giugno 2025. Il documento rivela che:

  • Green attualmente non possiede titoli o strumenti derivati di NeoGenomics
  • Ricopre il ruolo di Direttrice ma non detiene altre cariche (come dirigente o proprietaria del 10%)
  • La dichiarazione è stata presentata individualmente, non come parte di un gruppo
  • Il documento è stato firmato da Ali Olivo come Procuratore il 24 giugno 2025

La presentazione di questo Modulo 3 è un requisito normativo standard per i nuovi dirigenti aziendali ai sensi della Sezione 16(a) del Securities Exchange Act del 1934, che stabilisce la loro posizione iniziale di proprietà al momento dell'assunzione del ruolo.

NeoGenomics ha presentado un Formulario 3 (Declaración Inicial de Propiedad Beneficiaria) anunciando el nombramiento de Marjorie C. Green como Directora de la empresa, con efecto a partir del 19 de junio de 2025. La presentación revela que:

  • Green actualmente no posee valores ni derivados de NeoGenomics
  • Desempeña el cargo de Directora pero no ocupa otras posiciones (como Oficial o propietario del 10%)
  • La presentación se realizó de forma individual, no como parte de un grupo
  • El documento fue firmado por Ali Olivo como Apoderado el 24 de junio de 2025

Este Formulario 3 es un requisito regulatorio estándar para los nuevos directivos de la empresa bajo la Sección 16(a) de la Ley de Bolsa de Valores de 1934, estableciendo su posición inicial de propiedad al asumir su cargo.

NeoGenomicsëŠ� 2025ë…� 6ì›� 19ì¼ë¶€ë¡� 회사 ì´ì‚¬ë¡� Marjorie C. Greenë¥� 임명했ìŒì� 알리ëŠ� Form 3(초기 ìˆ˜ìµ ì†Œìœ ê¶� ì‹ ê³ ì„�)ë¥� 제출했습니다. 제출서ì—ëŠ� ë‹¤ìŒ ë‚´ìš©ì� í¬í•¨ë˜ì–´ 있습니다:

  • Greenì€ í˜„ìž¬ NeoGenomicsì� ì¦ê¶Œ ë˜ëŠ” íŒŒìƒ ì¦ê¶Œì� 보유하고 있지 않습니다
  • ì´ì‚¬ë¡� ìž¬ì§ ì¤‘ì´ë©� 다른 ì§ì±…(ìž„ì› ë˜ëŠ” 10% 소유ìž� ë“�)ì€ ì—†ìŠµë‹ˆë‹¤
  • ì œì¶œì€ ê·¸ë£¹ì� 아닌 ê°œì¸ ìžê²©ìœ¼ë¡œ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�
  • 서류ëŠ� 2025ë…� 6ì›� 24ì� Ali Olivoê°€ 대리ì¸ìœ¼ë¡œ 서명했습니다

ì� Form 3 ì œì¶œì€ 1934ë…� ì¦ê¶Œê±°ëž˜ë²� ì �16(a)ì¡°ì— ë”°ë¥¸ ì‹ ê·œ ë‚´ë¶€ìžì— 대í•� 표준 규제 요건으로, ì—­í• ì� 맡으면서 초기 소유ê¶� 위치ë¥� 확립하는 절차입니ë‹�.

NeoGenomics a déposé un formulaire 3 (Déclaration initiale de propriété bénéficiaire) annonçant la nomination de Marjorie C. Green en tant que directrice de la société, effective à partir du 19 juin 2025. Le dépôt révèle que :

  • Green ne possède actuellement aucun titre ou instrument dérivé de NeoGenomics
  • Elle occupe le poste de directrice mais ne détient aucune autre fonction (telle que dirigeante ou propriétaire à 10%)
  • Le dépôt a été soumis individuellement, et non en groupe
  • Le document a été signé par Ali Olivo en tant que mandataire le 24 juin 2025

Ce dépôt de formulaire 3 est une exigence réglementaire standard pour les nouveaux initiés de la société en vertu de la section 16(a) du Securities Exchange Act de 1934, établissant leur position initiale de propriété lors de la prise de fonction.

NeoGenomics hat ein Formular 3 (Erklärung über den anfänglichen wirtschaftlichen Eigentümer) eingereicht, in dem die Ernennung von Marjorie C. Green als Direktorin des Unternehmens mit Wirkung zum 19. Juni 2025 bekanntgegeben wird. Die Einreichung offenbart, dass:

  • Green derzeit keine Wertpapiere oder derivative Wertpapiere von NeoGenomics besitzt
  • Sie als Direktorin tätig ist, aber keine weiteren Positionen innehat (wie z.B. leitende Angestellte oder 10%-Eigentümerin)
  • Die Einreichung individuell erfolgte, nicht als Teil einer Gruppe
  • Das Dokument wurde am 24. Juni 2025 von Ali Olivo als Bevollmächtigter unterzeichnet

Dieses Formular 3 ist eine standardmäßige regulatorische Anforderung für neue Insider des Unternehmens gemäß Abschnitt 16(a) des Securities Exchange Act von 1934, die ihre anfängliche Eigentümerposition bei Übernahme ihrer Rolle festlegt.

Positive
  • None.
Negative
  • None.

NeoGenomics ha presentato un Modulo 3 (Dichiarazione Iniziale di Proprietà Beneficiaria) annunciando la nomina di Marjorie C. Green come Direttrice della società, con effetto dal 19 giugno 2025. Il documento rivela che:

  • Green attualmente non possiede titoli o strumenti derivati di NeoGenomics
  • Ricopre il ruolo di Direttrice ma non detiene altre cariche (come dirigente o proprietaria del 10%)
  • La dichiarazione è stata presentata individualmente, non come parte di un gruppo
  • Il documento è stato firmato da Ali Olivo come Procuratore il 24 giugno 2025

La presentazione di questo Modulo 3 è un requisito normativo standard per i nuovi dirigenti aziendali ai sensi della Sezione 16(a) del Securities Exchange Act del 1934, che stabilisce la loro posizione iniziale di proprietà al momento dell'assunzione del ruolo.

NeoGenomics ha presentado un Formulario 3 (Declaración Inicial de Propiedad Beneficiaria) anunciando el nombramiento de Marjorie C. Green como Directora de la empresa, con efecto a partir del 19 de junio de 2025. La presentación revela que:

  • Green actualmente no posee valores ni derivados de NeoGenomics
  • Desempeña el cargo de Directora pero no ocupa otras posiciones (como Oficial o propietario del 10%)
  • La presentación se realizó de forma individual, no como parte de un grupo
  • El documento fue firmado por Ali Olivo como Apoderado el 24 de junio de 2025

Este Formulario 3 es un requisito regulatorio estándar para los nuevos directivos de la empresa bajo la Sección 16(a) de la Ley de Bolsa de Valores de 1934, estableciendo su posición inicial de propiedad al asumir su cargo.

NeoGenomicsëŠ� 2025ë…� 6ì›� 19ì¼ë¶€ë¡� 회사 ì´ì‚¬ë¡� Marjorie C. Greenë¥� 임명했ìŒì� 알리ëŠ� Form 3(초기 ìˆ˜ìµ ì†Œìœ ê¶� ì‹ ê³ ì„�)ë¥� 제출했습니다. 제출서ì—ëŠ� ë‹¤ìŒ ë‚´ìš©ì� í¬í•¨ë˜ì–´ 있습니다:

  • Greenì€ í˜„ìž¬ NeoGenomicsì� ì¦ê¶Œ ë˜ëŠ” íŒŒìƒ ì¦ê¶Œì� 보유하고 있지 않습니다
  • ì´ì‚¬ë¡� ìž¬ì§ ì¤‘ì´ë©� 다른 ì§ì±…(ìž„ì› ë˜ëŠ” 10% 소유ìž� ë“�)ì€ ì—†ìŠµë‹ˆë‹¤
  • ì œì¶œì€ ê·¸ë£¹ì� 아닌 ê°œì¸ ìžê²©ìœ¼ë¡œ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�
  • 서류ëŠ� 2025ë…� 6ì›� 24ì� Ali Olivoê°€ 대리ì¸ìœ¼ë¡œ 서명했습니다

ì� Form 3 ì œì¶œì€ 1934ë…� ì¦ê¶Œê±°ëž˜ë²� ì �16(a)ì¡°ì— ë”°ë¥¸ ì‹ ê·œ ë‚´ë¶€ìžì— 대í•� 표준 규제 요건으로, ì—­í• ì� 맡으면서 초기 소유ê¶� 위치ë¥� 확립하는 절차입니ë‹�.

NeoGenomics a déposé un formulaire 3 (Déclaration initiale de propriété bénéficiaire) annonçant la nomination de Marjorie C. Green en tant que directrice de la société, effective à partir du 19 juin 2025. Le dépôt révèle que :

  • Green ne possède actuellement aucun titre ou instrument dérivé de NeoGenomics
  • Elle occupe le poste de directrice mais ne détient aucune autre fonction (telle que dirigeante ou propriétaire à 10%)
  • Le dépôt a été soumis individuellement, et non en groupe
  • Le document a été signé par Ali Olivo en tant que mandataire le 24 juin 2025

Ce dépôt de formulaire 3 est une exigence réglementaire standard pour les nouveaux initiés de la société en vertu de la section 16(a) du Securities Exchange Act de 1934, établissant leur position initiale de propriété lors de la prise de fonction.

NeoGenomics hat ein Formular 3 (Erklärung über den anfänglichen wirtschaftlichen Eigentümer) eingereicht, in dem die Ernennung von Marjorie C. Green als Direktorin des Unternehmens mit Wirkung zum 19. Juni 2025 bekanntgegeben wird. Die Einreichung offenbart, dass:

  • Green derzeit keine Wertpapiere oder derivative Wertpapiere von NeoGenomics besitzt
  • Sie als Direktorin tätig ist, aber keine weiteren Positionen innehat (wie z.B. leitende Angestellte oder 10%-Eigentümerin)
  • Die Einreichung individuell erfolgte, nicht als Teil einer Gruppe
  • Das Dokument wurde am 24. Juni 2025 von Ali Olivo als Bevollmächtigter unterzeichnet

Dieses Formular 3 ist eine standardmäßige regulatorische Anforderung für neue Insider des Unternehmens gemäß Abschnitt 16(a) des Securities Exchange Act von 1934, die ihre anfängliche Eigentümerposition bei Übernahme ihrer Rolle festlegt.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Green Marjorie C

(Last) (First) (Middle)
9490 NEOGENOMICS WAY

(Street)
FORT MYERS FL 33912

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/19/2025
3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
No securities are beneficially owned.
/s/ Ali Olivo, Attorney-in-Fact 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the new director appointed to NeoGenomics (NEO) board in June 2025?

Marjorie C. Green was appointed as a Director of NeoGenomics (NEO) as reported in the Form 3 filing dated June 28, 2025. The appointment was effective June 19, 2025.

Does Marjorie Green own any shares of NeoGenomics (NEO) upon joining the board?

According to the Form 3 filing, Marjorie Green owns no securities of NeoGenomics (NEO) at the time of her appointment. The filing explicitly states 'No securities are beneficially owned.'

What position does Marjorie Green hold at NeoGenomics (NEO)?

Marjorie Green serves as a Director at NeoGenomics (NEO), as indicated by the 'X' marked in the Director box under Section 4 of the Form 3 filing. She does not hold any other officer positions or have 10% ownership in the company.

When did Marjorie Green join the NeoGenomics (NEO) board of directors?

Marjorie Green joined the NeoGenomics (NEO) board of directors on June 19, 2025, as indicated by the 'Date of Event Requiring Statement' in the Form 3 filing.
Neogenomics Inc

NASDAQ:NEO

NEO Rankings

NEO Latest News

NEO Latest SEC Filings

NEO Stock Data

809.49M
127.16M
1.23%
102.53%
2.71%
Diagnostics & Research
Services-testing Laboratories
United States
FORT MYERS